These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 36969232)
21. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094 [TBL] [Abstract][Full Text] [Related]
23. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
24. Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma. Zhang A; He X; Zhang C; Tang X BMC Med Genomics; 2024 Feb; 17(1):53. PubMed ID: 38365684 [TBL] [Abstract][Full Text] [Related]
25. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas. Ma B; Li H; Qiao J; Meng T; Yu R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959 [TBL] [Abstract][Full Text] [Related]
26. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma. Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269 [TBL] [Abstract][Full Text] [Related]
27. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
28. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma. Zou J; Chu S; Bao Q; Zhang Y Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795 [TBL] [Abstract][Full Text] [Related]
29. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
30. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma. Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061 [TBL] [Abstract][Full Text] [Related]
31. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature. Liu L; Liu Q Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945 [TBL] [Abstract][Full Text] [Related]
32. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma. Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284 [TBL] [Abstract][Full Text] [Related]
33. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma. Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553 [TBL] [Abstract][Full Text] [Related]
34. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
35. A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma. Du K; Zou J; Wang B; Liu C; Khan M; Xie T; Huang X; Shen P; Tian Y; Yuan Y Front Immunol; 2022; 13():857934. PubMed ID: 35844514 [TBL] [Abstract][Full Text] [Related]
36. A circadian rhythm-related gene signature for prognosis, invasion and immune microenvironment of breast cancer. Wang MH; Liu X; Wang Q; Zhang HW Front Genet; 2022; 13():1104338. PubMed ID: 36685904 [No Abstract] [Full Text] [Related]
37. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
38. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC. Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012 [TBL] [Abstract][Full Text] [Related]
39. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma. Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883 [TBL] [Abstract][Full Text] [Related]
40. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation. Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K Front Immunol; 2023; 14():1190678. PubMed ID: 37691922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]